Board of Directors<\/h3>\n ![\"\"](\"https:\/\/www.compumedics.com.au\/wp-content\/uploads\/2018\/09\/David-Burton-2018-sharp-150x150.jpg\")
<\/p>\n
DR. DAVID BURTON
\nExecutive Chairman<\/strong><\/h5>\nDavid Burton, Ph.D., is the founder, Chairman and CEO of Compumedics. After establishment of Compumedics the company was listed on the ASX in 2000, and has been awarded 24 awards for design, innovation, business and exports including the Australian Exporter of the Year in 1998 and Small Business of the Year in 1999.<\/p>\n
Dr. Burton started his career at the Bureau of Meteorology, where he studied radar techniques and electronic equipment. He founded Linear Transfer Pty Ltd, which designed, manufactured and marketed high fidelity recording and sound equipment. He was awarded an Associate Diploma in Engineering (Electronics) by the Royal Melbourne Institute of Technology and a Ph.D. (Eng. Sc.) by Monash University, Melbourne (Australia). Dr. Burton\u2019s engineering background includes the design and project management of the Compumedics\u2019 first sleep laboratory and portable sleep systems.<\/p>\n
Dr. Burton has authored 150 patents or patent applications across more than 20 families of patents that form part of Compumedics\u2019 intellectual property.<\/p>\n
Dr. Burton has served as an advisor for the Victorian Government as a member of the Council for Knowledge, Innovation, Science and Engineering (KISE), being the Victorian Government\u2019s key advisory body on issues and policies focusing on science and innovation. Dr. Burton was presented the Clunies Ross National Science and Technology Award in 2002 for his development of innovative sleep monitoring technology.<\/p>\n
He was awarded the 2003 Centenary Medal by the Prime Minister and Governor General of Australia for outstanding contribution to science and technology, particularly public science policy. In 2003 Dr. Burton was awarded the Ernst & Young Victorian Entrepreneur of the year award for technology, communications, E-commerce and life sciences. In 2007 Dr. Burton was inducted into the Victorian Manufacturing Hall of Fame in recognition of manufacturing achievements and world-wide medical device exports. Dr. Burton served as a Victorian Government adviser as a Board member of the Design Victoria (2008-2011), was appointed to the Academy of Technological Science and Engineering (ATSE) committee in 2012 and in recognition of his outstanding contribution to the profession of Biomedical Engineering was awarded the 2012 David Dewhurst Award by Engineers Australia, College of Biomedical Engineers.<\/p>\n
\n![\"david-lawsonnew1\"](\"https:\/\/www.compumedics.com.au\/wp-content\/uploads\/2016\/09\/david-lawsonnew1.jpg\")
<\/p>\n
MR. DAVID LAWSON
\nExecutive Director<\/strong><\/h5>\nMr. Lawson has been Chief Financial Office and the Company Secretary of the Company for over nineteen years. In that time, Mr. Lawson has been extensively involved in the development of the Company including the Initial Public Offering of shares in the Company, the subsequent offshore acquisitions in the US and Germany, private equity placements and the recent refinancing of the Company. Mr. Lawson also has been involved in the operational turn around of the Company and brings a significant amount of experience and knowledge to the Board.<\/p>\n
<\/div>\n\n
\n<\/div>\n<\/div>\n![\"\"](\"https:\/\/www.compumedics.com.au\/wp-content\/uploads\/2024\/08\/Rod_northCropped-249x300-1.jpg\")
<\/div>\n\nMR. ROD NORTH
\nNon-Executive Director<\/strong><\/h5>\n<\/div>\n\nMr Rod North has been working in the financial services & corporate sector for 30 years, having held leading roles in share broking, investment and funds management and provided investor relations, media & PR services to a large range of ASX listed companies over the past 17 years. He has extensive experience in company analysis and financial management. He has served on a number of investment committees in funds management. He has also acted in high-level corporate advisory roles to private and public companies at senior executive and board level, advising on capital raisings, communication and investor relations strategies.<\/p>\n<\/div>\n<\/div>\n
Management<\/h3>\n <\/p>\n
\n<\/p>\n
DR. DAVID BURTON
\n<\/strong>Executive Chairman, CEO<\/h5>\n<\/div>\n\n<\/p>\n
MR. DAVID LAWSON
\n<\/strong>Chief Financial Officer & Company Secretary<\/h5>\n<\/div>\n\n![\"\"](\"https:\/\/www.compumedics.com.au\/wp-content\/uploads\/2018\/09\/Warwick-AR-web.jpg\")
<\/p>\n
MR. WARWICK FREEMAN
\n<\/strong>Chief Technology Officer<\/h5>\n<\/div>\n\n<\/h5>\n<\/div>\n<\/div>\n Medical Advisory Board<\/h3>\n Compumedics has assembled a group of international medical practitioners and researchers to assist the Company in remaining at the forefront of medical diagnosis and patient monitoring.<\/h3>\nMembers of the Advisory Board have been drawn from sleep, respiratory and cardiology areas.<\/h3>\n<\/h5>\n
\n
![\"david-burtonnew\"](\"http:\/\/www.compumedics.com.au\/wp-content\/uploads\/2016\/09\/david-burtonnew.jpg\")
<\/p>\n
DR. DAVID BURTON<\/strong><\/h5>\n\n- Executive Chairman, founder, Chairman and CEO of Compumedics<\/li>\n
- Heads up Compumedics Medical Innovations Division<\/li>\n
- Authored >100 patents or applications across > 20 families<\/li>\n<\/ul>\n
<\/p>\n
\n![\"ian-colrain\"](\"http:\/\/www.compumedics.com.au\/wp-content\/uploads\/2016\/09\/Ian-Colrain.jpg\")
<\/strong><\/h5>\nPROF. IAN COLRAIN, PH.D.<\/strong><\/h5>\n\n- Senior Vice President for\u00a0Stanford Research Institute (SRI) Biosciences (USA)<\/li>\n
- Section Head of Brain Sciences at SRI\u00a0International (USA)<\/li>\n
- Professional Fellow in Psychology at the University of Melbourne (AU)<\/li>\n<\/ul>\n
<\/p>\n
\n![\"patrice-bourgin\"](\"http:\/\/www.compumedics.com.au\/wp-content\/uploads\/2016\/09\/Patrice-bourgin.jpg\")
<\/strong><\/h5>\nPROF. DR. PATRICE BOURGIN M.D., PH.D.<\/strong><\/h5>\n\n- Professor of Neurology at the\u00a0Strasbourg University Hospital, University of Strasbourg (France)<\/li>\n
- Director of Sleep Disorders Centre Strasbourg University Hospital<\/li>\n
- Head of Research Team “Light, Circadian Rhythms, Sleep Homeostasis and Neuropsychiatry.<\/li>\n<\/ul>\n
<\/p>\n
\n![\"john-ebersole\"](\"http:\/\/www.compumedics.com.au\/wp-content\/uploads\/2016\/09\/John-Ebersole.jpg\")
<\/strong><\/h5>\nPROF.\u00a0JOHN EBERSOLE, MD<\/strong><\/h5>\n\n- Internationally recognized authority on epilepsy and EEG with a main clinical interest in treating patients with intractable epilepsy<\/li>\n
- Director of University of Chicago Adult Epilepsy Center<\/li>\n
- Medical Director of the Illinois MEG Center<\/li>\n
- Editor-in-Chief of the Journal of Clinical Neurophysiology<\/li>\n<\/ul>\n<\/div>\n <\/div>\n
<\/p>\n
DR. DAVID BURTON
\nExecutive Chairman<\/strong><\/h5>\nDavid Burton, Ph.D., is the founder, Chairman and CEO of Compumedics. After establishment of Compumedics the company was listed on the ASX in 2000, and has been awarded 24 awards for design, innovation, business and exports including the Australian Exporter of the Year in 1998 and Small Business of the Year in 1999.<\/p>\n
Dr. Burton started his career at the Bureau of Meteorology, where he studied radar techniques and electronic equipment. He founded Linear Transfer Pty Ltd, which designed, manufactured and marketed high fidelity recording and sound equipment. He was awarded an Associate Diploma in Engineering (Electronics) by the Royal Melbourne Institute of Technology and a Ph.D. (Eng. Sc.) by Monash University, Melbourne (Australia). Dr. Burton\u2019s engineering background includes the design and project management of the Compumedics\u2019 first sleep laboratory and portable sleep systems.<\/p>\n
Dr. Burton has authored 150 patents or patent applications across more than 20 families of patents that form part of Compumedics\u2019 intellectual property.<\/p>\n
Dr. Burton has served as an advisor for the Victorian Government as a member of the Council for Knowledge, Innovation, Science and Engineering (KISE), being the Victorian Government\u2019s key advisory body on issues and policies focusing on science and innovation. Dr. Burton was presented the Clunies Ross National Science and Technology Award in 2002 for his development of innovative sleep monitoring technology.<\/p>\n
He was awarded the 2003 Centenary Medal by the Prime Minister and Governor General of Australia for outstanding contribution to science and technology, particularly public science policy. In 2003 Dr. Burton was awarded the Ernst & Young Victorian Entrepreneur of the year award for technology, communications, E-commerce and life sciences. In 2007 Dr. Burton was inducted into the Victorian Manufacturing Hall of Fame in recognition of manufacturing achievements and world-wide medical device exports. Dr. Burton served as a Victorian Government adviser as a Board member of the Design Victoria (2008-2011), was appointed to the Academy of Technological Science and Engineering (ATSE) committee in 2012 and in recognition of his outstanding contribution to the profession of Biomedical Engineering was awarded the 2012 David Dewhurst Award by Engineers Australia, College of Biomedical Engineers.<\/p>\n
\n<\/p>\n
MR. DAVID LAWSON
\nExecutive Director<\/strong><\/h5>\nMr. Lawson has been Chief Financial Office and the Company Secretary of the Company for over nineteen years. In that time, Mr. Lawson has been extensively involved in the development of the Company including the Initial Public Offering of shares in the Company, the subsequent offshore acquisitions in the US and Germany, private equity placements and the recent refinancing of the Company. Mr. Lawson also has been involved in the operational turn around of the Company and brings a significant amount of experience and knowledge to the Board.<\/p>\n
<\/div>\n\n
\n<\/div>\n<\/div>\n<\/div>\n\nMR. ROD NORTH
\nNon-Executive Director<\/strong><\/h5>\n<\/div>\n\nMr Rod North has been working in the financial services & corporate sector for 30 years, having held leading roles in share broking, investment and funds management and provided investor relations, media & PR services to a large range of ASX listed companies over the past 17 years. He has extensive experience in company analysis and financial management. He has served on a number of investment committees in funds management. He has also acted in high-level corporate advisory roles to private and public companies at senior executive and board level, advising on capital raisings, communication and investor relations strategies.<\/p>\n<\/div>\n<\/div>\n
Management<\/h3>\n <\/p>\n
\n<\/p>\n
DR. DAVID BURTON
\n<\/strong>Executive Chairman, CEO<\/h5>\n<\/div>\n\n<\/p>\n
MR. DAVID LAWSON
\n<\/strong>Chief Financial Officer & Company Secretary<\/h5>\n<\/div>\n\n<\/p>\n
MR. WARWICK FREEMAN
\n<\/strong>Chief Technology Officer<\/h5>\n<\/div>\n\n<\/h5>\n<\/div>\n<\/div>\n Medical Advisory Board<\/h3>\n Compumedics has assembled a group of international medical practitioners and researchers to assist the Company in remaining at the forefront of medical diagnosis and patient monitoring.<\/h3>\nMembers of the Advisory Board have been drawn from sleep, respiratory and cardiology areas.<\/h3>\n<\/h5>\n
\n
<\/p>\n
DR. DAVID BURTON<\/strong><\/h5>\n\n- Executive Chairman, founder, Chairman and CEO of Compumedics<\/li>\n
- Heads up Compumedics Medical Innovations Division<\/li>\n
- Authored >100 patents or applications across > 20 families<\/li>\n<\/ul>\n
<\/p>\n
\n<\/strong><\/h5>\nPROF. IAN COLRAIN, PH.D.<\/strong><\/h5>\n\n- Senior Vice President for\u00a0Stanford Research Institute (SRI) Biosciences (USA)<\/li>\n
- Section Head of Brain Sciences at SRI\u00a0International (USA)<\/li>\n
- Professional Fellow in Psychology at the University of Melbourne (AU)<\/li>\n<\/ul>\n
<\/p>\n
\n<\/strong><\/h5>\nPROF. DR. PATRICE BOURGIN M.D., PH.D.<\/strong><\/h5>\n\n- Professor of Neurology at the\u00a0Strasbourg University Hospital, University of Strasbourg (France)<\/li>\n
- Director of Sleep Disorders Centre Strasbourg University Hospital<\/li>\n
- Head of Research Team “Light, Circadian Rhythms, Sleep Homeostasis and Neuropsychiatry.<\/li>\n<\/ul>\n
<\/p>\n
\n<\/strong><\/h5>\nPROF.\u00a0JOHN EBERSOLE, MD<\/strong><\/h5>\n\n- Internationally recognized authority on epilepsy and EEG with a main clinical interest in treating patients with intractable epilepsy<\/li>\n
- Director of University of Chicago Adult Epilepsy Center<\/li>\n
- Medical Director of the Illinois MEG Center<\/li>\n
- Editor-in-Chief of the Journal of Clinical Neurophysiology<\/li>\n<\/ul>\n<\/div>\n <\/div>\n
<\/p>\n\nExecutive Director<\/strong><\/h5>\n
Mr. Lawson has been Chief Financial Office and the Company Secretary of the Company for over nineteen years. In that time, Mr. Lawson has been extensively involved in the development of the Company including the Initial Public Offering of shares in the Company, the subsequent offshore acquisitions in the US and Germany, private equity placements and the recent refinancing of the Company. Mr. Lawson also has been involved in the operational turn around of the Company and brings a significant amount of experience and knowledge to the Board.<\/p>\n
\n<\/div>\n
<\/div>\nMR. ROD NORTH
\nNon-Executive Director<\/strong><\/h5>\n<\/div>\n\nMr Rod North has been working in the financial services & corporate sector for 30 years, having held leading roles in share broking, investment and funds management and provided investor relations, media & PR services to a large range of ASX listed companies over the past 17 years. He has extensive experience in company analysis and financial management. He has served on a number of investment committees in funds management. He has also acted in high-level corporate advisory roles to private and public companies at senior executive and board level, advising on capital raisings, communication and investor relations strategies.<\/p>\n<\/div>\n<\/div>\n
Management<\/h3>\n <\/p>\n
\n<\/p>\n
DR. DAVID BURTON
\n<\/strong>Executive Chairman, CEO<\/h5>\n<\/div>\n\n<\/p>\n
MR. DAVID LAWSON
\n<\/strong>Chief Financial Officer & Company Secretary<\/h5>\n<\/div>\n\n<\/p>\n
MR. WARWICK FREEMAN
\n<\/strong>Chief Technology Officer<\/h5>\n<\/div>\n\n<\/h5>\n<\/div>\n<\/div>\n Medical Advisory Board<\/h3>\n Compumedics has assembled a group of international medical practitioners and researchers to assist the Company in remaining at the forefront of medical diagnosis and patient monitoring.<\/h3>\nMembers of the Advisory Board have been drawn from sleep, respiratory and cardiology areas.<\/h3>\n<\/h5>\n
\n
<\/p>\n
DR. DAVID BURTON<\/strong><\/h5>\n\n- Executive Chairman, founder, Chairman and CEO of Compumedics<\/li>\n
- Heads up Compumedics Medical Innovations Division<\/li>\n
- Authored >100 patents or applications across > 20 families<\/li>\n<\/ul>\n
<\/p>\n
\n<\/strong><\/h5>\nPROF. IAN COLRAIN, PH.D.<\/strong><\/h5>\n\n- Senior Vice President for\u00a0Stanford Research Institute (SRI) Biosciences (USA)<\/li>\n
- Section Head of Brain Sciences at SRI\u00a0International (USA)<\/li>\n
- Professional Fellow in Psychology at the University of Melbourne (AU)<\/li>\n<\/ul>\n
<\/p>\n
\n<\/strong><\/h5>\nPROF. DR. PATRICE BOURGIN M.D., PH.D.<\/strong><\/h5>\n\n- Professor of Neurology at the\u00a0Strasbourg University Hospital, University of Strasbourg (France)<\/li>\n
- Director of Sleep Disorders Centre Strasbourg University Hospital<\/li>\n
- Head of Research Team “Light, Circadian Rhythms, Sleep Homeostasis and Neuropsychiatry.<\/li>\n<\/ul>\n
<\/p>\n
\n<\/strong><\/h5>\nPROF.\u00a0JOHN EBERSOLE, MD<\/strong><\/h5>\n\n- Internationally recognized authority on epilepsy and EEG with a main clinical interest in treating patients with intractable epilepsy<\/li>\n
- Director of University of Chicago Adult Epilepsy Center<\/li>\n
- Medical Director of the Illinois MEG Center<\/li>\n
- Editor-in-Chief of the Journal of Clinical Neurophysiology<\/li>\n<\/ul>\n<\/div>\n <\/div>\n
Mr Rod North has been working in the financial services & corporate sector for 30 years, having held leading roles in share broking, investment and funds management and provided investor relations, media & PR services to a large range of ASX listed companies over the past 17 years. He has extensive experience in company analysis and financial management. He has served on a number of investment committees in funds management. He has also acted in high-level corporate advisory roles to private and public companies at senior executive and board level, advising on capital raisings, communication and investor relations strategies.<\/p>\n<\/div>\n<\/div>\n
Management<\/h3>\n <\/p>\n
\n<\/p>\n
DR. DAVID BURTON
\n<\/strong>Executive Chairman, CEO<\/h5>\n<\/div>\n\n<\/p>\n
MR. DAVID LAWSON
\n<\/strong>Chief Financial Officer & Company Secretary<\/h5>\n<\/div>\n\n<\/p>\n
MR. WARWICK FREEMAN
\n<\/strong>Chief Technology Officer<\/h5>\n<\/div>\n\n<\/h5>\n<\/div>\n<\/div>\n Medical Advisory Board<\/h3>\n Compumedics has assembled a group of international medical practitioners and researchers to assist the Company in remaining at the forefront of medical diagnosis and patient monitoring.<\/h3>\nMembers of the Advisory Board have been drawn from sleep, respiratory and cardiology areas.<\/h3>\n<\/h5>\n
\n
<\/p>\n
DR. DAVID BURTON<\/strong><\/h5>\n\n- Executive Chairman, founder, Chairman and CEO of Compumedics<\/li>\n
- Heads up Compumedics Medical Innovations Division<\/li>\n
- Authored >100 patents or applications across > 20 families<\/li>\n<\/ul>\n
<\/p>\n
\n<\/strong><\/h5>\nPROF. IAN COLRAIN, PH.D.<\/strong><\/h5>\n\n- Senior Vice President for\u00a0Stanford Research Institute (SRI) Biosciences (USA)<\/li>\n
- Section Head of Brain Sciences at SRI\u00a0International (USA)<\/li>\n
- Professional Fellow in Psychology at the University of Melbourne (AU)<\/li>\n<\/ul>\n
<\/p>\n
\n<\/strong><\/h5>\nPROF. DR. PATRICE BOURGIN M.D., PH.D.<\/strong><\/h5>\n\n- Professor of Neurology at the\u00a0Strasbourg University Hospital, University of Strasbourg (France)<\/li>\n
- Director of Sleep Disorders Centre Strasbourg University Hospital<\/li>\n
- Head of Research Team “Light, Circadian Rhythms, Sleep Homeostasis and Neuropsychiatry.<\/li>\n<\/ul>\n
<\/p>\n
\n<\/strong><\/h5>\nPROF.\u00a0JOHN EBERSOLE, MD<\/strong><\/h5>\n\n- Internationally recognized authority on epilepsy and EEG with a main clinical interest in treating patients with intractable epilepsy<\/li>\n
- Director of University of Chicago Adult Epilepsy Center<\/li>\n
- Medical Director of the Illinois MEG Center<\/li>\n
- Editor-in-Chief of the Journal of Clinical Neurophysiology<\/li>\n<\/ul>\n<\/div>\n <\/div>\n
<\/p>\n
<\/p>\n
DR. DAVID BURTON
\n<\/strong>Executive Chairman, CEO<\/h5>\n<\/div>\n\n<\/p>\n
MR. DAVID LAWSON
\n<\/strong>Chief Financial Officer & Company Secretary<\/h5>\n<\/div>\n\n<\/p>\n
MR. WARWICK FREEMAN
\n<\/strong>Chief Technology Officer<\/h5>\n<\/div>\n\n<\/h5>\n<\/div>\n<\/div>\n Medical Advisory Board<\/h3>\n Compumedics has assembled a group of international medical practitioners and researchers to assist the Company in remaining at the forefront of medical diagnosis and patient monitoring.<\/h3>\nMembers of the Advisory Board have been drawn from sleep, respiratory and cardiology areas.<\/h3>\n<\/h5>\n
\n
<\/p>\n
DR. DAVID BURTON<\/strong><\/h5>\n\n- Executive Chairman, founder, Chairman and CEO of Compumedics<\/li>\n
- Heads up Compumedics Medical Innovations Division<\/li>\n
- Authored >100 patents or applications across > 20 families<\/li>\n<\/ul>\n
<\/p>\n
\n<\/strong><\/h5>\nPROF. IAN COLRAIN, PH.D.<\/strong><\/h5>\n\n- Senior Vice President for\u00a0Stanford Research Institute (SRI) Biosciences (USA)<\/li>\n
- Section Head of Brain Sciences at SRI\u00a0International (USA)<\/li>\n
- Professional Fellow in Psychology at the University of Melbourne (AU)<\/li>\n<\/ul>\n
<\/p>\n
\n<\/strong><\/h5>\nPROF. DR. PATRICE BOURGIN M.D., PH.D.<\/strong><\/h5>\n\n- Professor of Neurology at the\u00a0Strasbourg University Hospital, University of Strasbourg (France)<\/li>\n
- Director of Sleep Disorders Centre Strasbourg University Hospital<\/li>\n
- Head of Research Team “Light, Circadian Rhythms, Sleep Homeostasis and Neuropsychiatry.<\/li>\n<\/ul>\n
<\/p>\n
\n<\/strong><\/h5>\nPROF.\u00a0JOHN EBERSOLE, MD<\/strong><\/h5>\n\n- Internationally recognized authority on epilepsy and EEG with a main clinical interest in treating patients with intractable epilepsy<\/li>\n
- Director of University of Chicago Adult Epilepsy Center<\/li>\n
- Medical Director of the Illinois MEG Center<\/li>\n
- Editor-in-Chief of the Journal of Clinical Neurophysiology<\/li>\n<\/ul>\n<\/div>\n <\/div>\n
<\/p>\n
MR. DAVID LAWSON
\n<\/strong>Chief Financial Officer & Company Secretary<\/h5>\n<\/div>\n\n<\/p>\n
MR. WARWICK FREEMAN
\n<\/strong>Chief Technology Officer<\/h5>\n<\/div>\n\n<\/h5>\n<\/div>\n<\/div>\n Medical Advisory Board<\/h3>\n Compumedics has assembled a group of international medical practitioners and researchers to assist the Company in remaining at the forefront of medical diagnosis and patient monitoring.<\/h3>\nMembers of the Advisory Board have been drawn from sleep, respiratory and cardiology areas.<\/h3>\n<\/h5>\n
\n
<\/p>\n
DR. DAVID BURTON<\/strong><\/h5>\n\n- Executive Chairman, founder, Chairman and CEO of Compumedics<\/li>\n
- Heads up Compumedics Medical Innovations Division<\/li>\n
- Authored >100 patents or applications across > 20 families<\/li>\n<\/ul>\n
<\/p>\n
\n<\/strong><\/h5>\nPROF. IAN COLRAIN, PH.D.<\/strong><\/h5>\n\n- Senior Vice President for\u00a0Stanford Research Institute (SRI) Biosciences (USA)<\/li>\n
- Section Head of Brain Sciences at SRI\u00a0International (USA)<\/li>\n
- Professional Fellow in Psychology at the University of Melbourne (AU)<\/li>\n<\/ul>\n
<\/p>\n
\n<\/strong><\/h5>\nPROF. DR. PATRICE BOURGIN M.D., PH.D.<\/strong><\/h5>\n\n- Professor of Neurology at the\u00a0Strasbourg University Hospital, University of Strasbourg (France)<\/li>\n
- Director of Sleep Disorders Centre Strasbourg University Hospital<\/li>\n
- Head of Research Team “Light, Circadian Rhythms, Sleep Homeostasis and Neuropsychiatry.<\/li>\n<\/ul>\n
<\/p>\n
\n<\/strong><\/h5>\nPROF.\u00a0JOHN EBERSOLE, MD<\/strong><\/h5>\n\n- Internationally recognized authority on epilepsy and EEG with a main clinical interest in treating patients with intractable epilepsy<\/li>\n
- Director of University of Chicago Adult Epilepsy Center<\/li>\n
- Medical Director of the Illinois MEG Center<\/li>\n
- Editor-in-Chief of the Journal of Clinical Neurophysiology<\/li>\n<\/ul>\n<\/div>\n <\/div>\n
<\/p>\n
MR. WARWICK FREEMAN
\n<\/strong>Chief Technology Officer<\/h5>\n<\/div>\n\n<\/h5>\n<\/div>\n<\/div>\n Medical Advisory Board<\/h3>\n Compumedics has assembled a group of international medical practitioners and researchers to assist the Company in remaining at the forefront of medical diagnosis and patient monitoring.<\/h3>\nMembers of the Advisory Board have been drawn from sleep, respiratory and cardiology areas.<\/h3>\n<\/h5>\n
\n
<\/p>\n
DR. DAVID BURTON<\/strong><\/h5>\n\n- Executive Chairman, founder, Chairman and CEO of Compumedics<\/li>\n
- Heads up Compumedics Medical Innovations Division<\/li>\n
- Authored >100 patents or applications across > 20 families<\/li>\n<\/ul>\n
<\/p>\n
\n<\/strong><\/h5>\nPROF. IAN COLRAIN, PH.D.<\/strong><\/h5>\n\n- Senior Vice President for\u00a0Stanford Research Institute (SRI) Biosciences (USA)<\/li>\n
- Section Head of Brain Sciences at SRI\u00a0International (USA)<\/li>\n
- Professional Fellow in Psychology at the University of Melbourne (AU)<\/li>\n<\/ul>\n
<\/p>\n
\n<\/strong><\/h5>\nPROF. DR. PATRICE BOURGIN M.D., PH.D.<\/strong><\/h5>\n\n- Professor of Neurology at the\u00a0Strasbourg University Hospital, University of Strasbourg (France)<\/li>\n
- Director of Sleep Disorders Centre Strasbourg University Hospital<\/li>\n
- Head of Research Team “Light, Circadian Rhythms, Sleep Homeostasis and Neuropsychiatry.<\/li>\n<\/ul>\n
<\/p>\n
\n<\/strong><\/h5>\nPROF.\u00a0JOHN EBERSOLE, MD<\/strong><\/h5>\n\n- Internationally recognized authority on epilepsy and EEG with a main clinical interest in treating patients with intractable epilepsy<\/li>\n
- Director of University of Chicago Adult Epilepsy Center<\/li>\n
- Medical Director of the Illinois MEG Center<\/li>\n
- Editor-in-Chief of the Journal of Clinical Neurophysiology<\/li>\n<\/ul>\n<\/div>\n <\/div>\n
<\/h5>\n<\/div>\n<\/div>\n Medical Advisory Board<\/h3>\n Compumedics has assembled a group of international medical practitioners and researchers to assist the Company in remaining at the forefront of medical diagnosis and patient monitoring.<\/h3>\nMembers of the Advisory Board have been drawn from sleep, respiratory and cardiology areas.<\/h3>\n<\/h5>\n
\n
<\/p>\n
DR. DAVID BURTON<\/strong><\/h5>\n\n- Executive Chairman, founder, Chairman and CEO of Compumedics<\/li>\n
- Heads up Compumedics Medical Innovations Division<\/li>\n
- Authored >100 patents or applications across > 20 families<\/li>\n<\/ul>\n
<\/p>\n
\n<\/strong><\/h5>\nPROF. IAN COLRAIN, PH.D.<\/strong><\/h5>\n\n- Senior Vice President for\u00a0Stanford Research Institute (SRI) Biosciences (USA)<\/li>\n
- Section Head of Brain Sciences at SRI\u00a0International (USA)<\/li>\n
- Professional Fellow in Psychology at the University of Melbourne (AU)<\/li>\n<\/ul>\n
<\/p>\n
\n<\/strong><\/h5>\nPROF. DR. PATRICE BOURGIN M.D., PH.D.<\/strong><\/h5>\n\n- Professor of Neurology at the\u00a0Strasbourg University Hospital, University of Strasbourg (France)<\/li>\n
- Director of Sleep Disorders Centre Strasbourg University Hospital<\/li>\n
- Head of Research Team “Light, Circadian Rhythms, Sleep Homeostasis and Neuropsychiatry.<\/li>\n<\/ul>\n
<\/p>\n
\n<\/strong><\/h5>\nPROF.\u00a0JOHN EBERSOLE, MD<\/strong><\/h5>\n\n- Internationally recognized authority on epilepsy and EEG with a main clinical interest in treating patients with intractable epilepsy<\/li>\n
- Director of University of Chicago Adult Epilepsy Center<\/li>\n
- Medical Director of the Illinois MEG Center<\/li>\n
- Editor-in-Chief of the Journal of Clinical Neurophysiology<\/li>\n<\/ul>\n<\/div>\n <\/div>\n
Compumedics has assembled a group of international medical practitioners and researchers to assist the Company in remaining at the forefront of medical diagnosis and patient monitoring.<\/h3>\nMembers of the Advisory Board have been drawn from sleep, respiratory and cardiology areas.<\/h3>\n<\/h5>\n
\n
<\/h5>\n
\n
<\/p>\n
DR. DAVID BURTON<\/strong><\/h5>\n\n- Executive Chairman, founder, Chairman and CEO of Compumedics<\/li>\n
- Heads up Compumedics Medical Innovations Division<\/li>\n
- Authored >100 patents or applications across > 20 families<\/li>\n<\/ul>\n
<\/p>\n
\n<\/strong><\/h5>\nPROF. IAN COLRAIN, PH.D.<\/strong><\/h5>\n\n- Senior Vice President for\u00a0Stanford Research Institute (SRI) Biosciences (USA)<\/li>\n
- Section Head of Brain Sciences at SRI\u00a0International (USA)<\/li>\n
- Professional Fellow in Psychology at the University of Melbourne (AU)<\/li>\n<\/ul>\n
<\/p>\n
\n<\/strong><\/h5>\nPROF. DR. PATRICE BOURGIN M.D., PH.D.<\/strong><\/h5>\n\n- Professor of Neurology at the\u00a0Strasbourg University Hospital, University of Strasbourg (France)<\/li>\n
- Director of Sleep Disorders Centre Strasbourg University Hospital<\/li>\n
- Head of Research Team “Light, Circadian Rhythms, Sleep Homeostasis and Neuropsychiatry.<\/li>\n<\/ul>\n
<\/p>\n
\n<\/strong><\/h5>\nPROF.\u00a0JOHN EBERSOLE, MD<\/strong><\/h5>\n\n- Internationally recognized authority on epilepsy and EEG with a main clinical interest in treating patients with intractable epilepsy<\/li>\n
- Director of University of Chicago Adult Epilepsy Center<\/li>\n
- Medical Director of the Illinois MEG Center<\/li>\n
- Editor-in-Chief of the Journal of Clinical Neurophysiology<\/li>\n<\/ul>\n<\/div>\n <\/div>\n
<\/p>\n
\n
<\/strong><\/h5>\nPROF. IAN COLRAIN, PH.D.<\/strong><\/h5>\n\n- Senior Vice President for\u00a0Stanford Research Institute (SRI) Biosciences (USA)<\/li>\n
- Section Head of Brain Sciences at SRI\u00a0International (USA)<\/li>\n
- Professional Fellow in Psychology at the University of Melbourne (AU)<\/li>\n<\/ul>\n
<\/p>\n
\n<\/strong><\/h5>\nPROF. DR. PATRICE BOURGIN M.D., PH.D.<\/strong><\/h5>\n\n- Professor of Neurology at the\u00a0Strasbourg University Hospital, University of Strasbourg (France)<\/li>\n
- Director of Sleep Disorders Centre Strasbourg University Hospital<\/li>\n
- Head of Research Team “Light, Circadian Rhythms, Sleep Homeostasis and Neuropsychiatry.<\/li>\n<\/ul>\n
<\/p>\n
\n<\/strong><\/h5>\nPROF.\u00a0JOHN EBERSOLE, MD<\/strong><\/h5>\n\n- Internationally recognized authority on epilepsy and EEG with a main clinical interest in treating patients with intractable epilepsy<\/li>\n
- Director of University of Chicago Adult Epilepsy Center<\/li>\n
- Medical Director of the Illinois MEG Center<\/li>\n
- Editor-in-Chief of the Journal of Clinical Neurophysiology<\/li>\n<\/ul>\n<\/div>\n <\/div>\n
- \n
- Senior Vice President for\u00a0Stanford Research Institute (SRI) Biosciences (USA)<\/li>\n
- Section Head of Brain Sciences at SRI\u00a0International (USA)<\/li>\n
- Professional Fellow in Psychology at the University of Melbourne (AU)<\/li>\n<\/ul>\n
<\/p>\n
\n<\/strong><\/h5>\nPROF. DR. PATRICE BOURGIN M.D., PH.D.<\/strong><\/h5>\n
- \n
- Professor of Neurology at the\u00a0Strasbourg University Hospital, University of Strasbourg (France)<\/li>\n
- Director of Sleep Disorders Centre Strasbourg University Hospital<\/li>\n
- Head of Research Team “Light, Circadian Rhythms, Sleep Homeostasis and Neuropsychiatry.<\/li>\n<\/ul>\n
<\/p>\n
\n<\/strong><\/h5>\nPROF.\u00a0JOHN EBERSOLE, MD<\/strong><\/h5>\n
- \n
- Internationally recognized authority on epilepsy and EEG with a main clinical interest in treating patients with intractable epilepsy<\/li>\n
- Director of University of Chicago Adult Epilepsy Center<\/li>\n
- Medical Director of the Illinois MEG Center<\/li>\n
- Editor-in-Chief of the Journal of Clinical Neurophysiology<\/li>\n<\/ul>\n<\/div>\n <\/div>\n